Neutrophil Dysfunction, Immature Granulocytes, and Cell-free DNA are Early Biomarkers of Sepsis in Burn-injured Patients: A Prospective Observational Cohort Study

Objective: The aim of this study was to measure neutrophil function longitudinally following burn injury and to examine the relationship between neutrophil dysfunction and sepsis. Background: Sepsis prevalence and its associated mortality is high following burn injury, and sepsis diagnosis is complicated by the ongoing inflammatory response. Previous studies have suggested that neutrophil dysfunction may underlie high infection rates and sepsis postburn; however, neutrophil dysfunction has not been thoroughly characterized over time in burns patients. Methods: Neutrophil phagocytosis, oxidative burst capacity, and neutrophil extracellular trap (NET) generation (NETosis) were measured from 1 day to up to 1 year postburn injury in 63 patients with major burns (≥15% total body surface area). In addition, immature granulocyte (IG) count, plasma cell-free DNA (cfDNA), and plasma citrullinated histone H3 (Cit H3) levels were measured. Results: Neutrophil function was reduced for 28 days postburn injury and to a greater degree in patients who developed sepsis, which was also characterized by elevated IG counts. Plasma cfDNA and Cit-H3, a specific marker of NETosis, were elevated during septic episodes. The combination of neutrophil phagocytic capacity, plasma cfDNA levels, and IG count at day 1 postinjury gave good discriminatory power for the identification of septic patients. Conclusion: Neutrophil function, IG count, and plasma cfDNA levels show potential as biomarkers for the prediction/early diagnosis of sepsis postburn injury and neutrophil dysfunction may actively contribute to the development of sepsis. Targeting neutrophil dysfunction and IG release may be a viable therapeutic intervention to help reduce the incidence of nosocomial infections and sepsis postburn.

[1]  Ronald G. Tompkins,et al.  Spontaneous Neutrophil Migration Patterns during Sepsis after Major Burns , 2014, PloS one.

[2]  O. Tasaki,et al.  Presence of Neutrophil Extracellular Traps and Citrullinated Histone H3 in the Bloodstream of Critically Ill Patients , 2014, PloS one.

[3]  B. Giraudeau,et al.  Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration* , 2014, Critical care medicine.

[4]  G. Shaked,et al.  Admission Cell Free DNA as a Prognostic Factor in Burns: Quantification by Use of a Direct Rapid Fluorometric Technique , 2014, BioMed research international.

[5]  P. C. Jackson,et al.  Revised Estimates of Mortality From the Birmingham Burn Centre, 2001–2010: A Continuing Analysis Over 65 Years , 2014, Annals of surgery.

[6]  D. Herndon,et al.  Occurrence of Multiorgan Dysfunction in Pediatric Burn Patients: Incidence and Clinical Outcome , 2014, Annals of surgery.

[7]  R. Chamberlain,et al.  The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? , 2013, Surgical infections.

[8]  A. Mócsai Diverse novel functions of neutrophils in immunity, inflammation, and beyond , 2013, The Journal of experimental medicine.

[9]  S. Fagan,et al.  Resolvin D2 restores neutrophil directionality and improves survival after burns , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. A. Farina,et al.  Curbing Inflammation in Burn Patients , 2013, International journal of inflammation.

[11]  D. Wichmann,et al.  Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis - a prospective, observational study , 2013, BMC Immunology.

[12]  M. Baun,et al.  Novel Predictors of Sepsis Outperform the American Burn Association Sepsis Criteria in the Burn Intensive Care Unit Patient , 2013, Journal of burn care & research : official publication of the American Burn Association.

[13]  D. Bautista-Rentero,et al.  Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis , 2012 .

[14]  D. Bautista-Rentero,et al.  Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. , 2012, Medicina intensiva.

[15]  S. Resino,et al.  A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. , 2012, Cytokine.

[16]  P. Dri,et al.  Killing by neutrophil extracellular traps: fact or folklore? , 2012, Blood.

[17]  M. Baun,et al.  Comparison of Mortality Associated With Sepsis in the Burn, Trauma, and General Intensive Care Unit Patient: A Systematic Review of the Literature , 2012, Shock.

[18]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[19]  D. King,et al.  Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. , 2011, Surgery.

[20]  K. Tschaikowsky,et al.  Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. , 2011, Journal of critical care.

[21]  E. Faist,et al.  Neutrophil-derived circulating free DNA (cf-DNA/NETs), a potential prognostic marker for mortality in patients with severe burn injury , 2010, European Journal of Trauma and Emergency Surgery.

[22]  D. Hosmer,et al.  Simplified estimates of the probability of death after burn injuries: extending and updating the baux score. , 2010, The Journal of trauma.

[23]  J. Cinatl,et al.  The clinical value of neutrophil extracellular traps , 2009, Medical Microbiology and Immunology.

[24]  J. Altrichter,et al.  NEUTROPHIL-DERIVED CIRCULATING FREE DNA (cf-DNA/NETs): A POTENTIAL PROGNOSTIC MARKER FOR POSTTRAUMATIC DEVELOPMENT OF INFLAMMATORY SECOND HIT AND SEPSIS , 2008, Shock.

[25]  P. J. Pretorius,et al.  The origin of circulating free DNA. , 2007, Clinical chemistry.

[26]  R. Gamelli,et al.  American Burn Association Consensus Conference to Define Sepsis and Infection in Burns , 2007, Journal of burn care & research : official publication of the American Burn Association.

[27]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[28]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[29]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[30]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[31]  P. Póvoa,et al.  C-reactive protein: a valuable marker of sepsis , 2002, Intensive Care Medicine.

[32]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[33]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[34]  R F Edlich,et al.  The abbreviated burn severity index. , 1982, Annals of emergency medicine.

[35]  D. Pilcher A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury , 1979 .

[36]  J. Alexander,et al.  A Sequential, Prospective Analysis of Immunologic Abnormalities and Infection Following Severe Thermal Injury , 1978, Annals of surgery.

[37]  M. Spreeuwenberg,et al.  The Origin of Circulating Free DNA , 2007 .

[38]  Z. Sheng,et al.  Neutrophil chemiluminescence in burned patients. , 1987, The Journal of trauma.